| Secondary outcome | ARNi | Valsartan | p-value | ||||
|
| n | Baseline | 90 days | n | Baseline | 90 days |
|
| Elevated EF | 50 | 30.4 ± 6.7 | 38.8 ± 8.1 | 50 | 30.6 ± 6.0 | 35.0 ± 7.9 | 0.017 |
| Decreased NT-proBNP | 50 | 3066.5 ± 1882.1 | 808.2 ± 592.5 | 50 | 3488.2 ± 2912.2 | 1886.4 ± 1017.8 | 0.000 |
| Elevated e-GFR | 50 | 53.4 ± 18.1 | 56.2 ± 16.6 | 48 | 46.6 ± 18.8 | 48.9 ± 22.3 | 0.045 |